MP18-03 THE CHINESE ANTI-CANCER ASSOCIATION GENITOURINARY CANCER COMMITTEE PROSTATE CANCER SCREENING PROGRAM: A PRELIMINARY REPORT AFTER RECRUITMENT OF 2162 MEN

Yongqiang Huang,Chengyuan Gu,Xiaojian Qin,Yuanyuan Qu,Jianfeng Yang,Jing Hong,li Liu,Kefa Zheng,Lihua Xu,Huaiping Zhao,Xiongxion Qian,Dingwei Ye

DOI: https://doi.org/10.1097/01.ju.0000555448.52970.09

2019-01-01

Abstract:You have accessJournal of UrologyProstate Cancer: Detection & Screening II (MP18)1 Apr 2019MP18-03 THE CHINESE ANTI-CANCER ASSOCIATION GENITOURINARY CANCER COMMITTEE PROSTATE CANCER SCREENING PROGRAM: A PRELIMINARY REPORT AFTER RECRUITMENT OF 2162 MEN Yongqiang Huang*, Chengyuan Gu, Xiaojian Qin, Yuanyuan Qu, Jianfeng Yang, Jing Hong, li Liu, Kefa Zheng, Lihua Xu, Huaiping Zhao, Xiongxion Qian, and Dingwei Ye Yongqiang Huang*Yongqiang Huang* More articles by this author , Chengyuan GuChengyuan Gu More articles by this author , Xiaojian QinXiaojian Qin More articles by this author , Yuanyuan QuYuanyuan Qu More articles by this author , Jianfeng YangJianfeng Yang More articles by this author , Jing HongJing Hong More articles by this author , li Liuli Liu More articles by this author , Kefa ZhengKefa Zheng More articles by this author , Lihua XuLihua Xu More articles by this author , Huaiping ZhaoHuaiping Zhao More articles by this author , Xiongxion QianXiongxion Qian More articles by this author , and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555448.52970.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: There is marked regional differences in the prostate cancer (PCa) incidence and mortality rates rate between China and the West. The incidence of PCa is increasing rapidly in China, the clinical stage of PCa patients is comparatively late and the overall survival rate is inferior to that reported in the developed countries. Though population-based PSA screening still is controversially discussed in the West, it is an effective measure to reduce the risk of death through early detection. The Chinese Anti-Cancer Association Genitourinary Cancer Committee Prostate Cancer Screening Program is currently the largest ongoing screening program in China and aims to accrue 50,000 men within 5 yrs in a prospective fashion. The program started in June 2017. METHODS: According to Chinese consensus of prostate cancer screening, eligible men aged 50 with life expectancy over 10 years or aged 45 with high risk (e.g. those with a first degree relative diagnosed with PCa; age >40 yrs with baseline PSA ≥ 1.0 μg/ml). The interviewer-administered questionnaire covered demographic characteristics and environmental exposure factors. Prostate-specific antigen (PSA) determination in serum with a cut-off of ≥4.0 ng/ml was the main screening test and indication for biopsy. The FRENDTM System is employed for a precise and rapid PSA detection. The Institutional Review Board of Fudan University Shanghai Cancer Center approved this study, and a written informed consent was obtained from all recruited individuals. RESULTS: 2, 162 men have been enrolled until October 2018. The median age was 70.0 yrs (45-85). Median PSA of theses participants was 1.21 ng/ml (range 0.01-25.0). Altogether, 11.0% (237 cases) had a confirmed PSA increase ≥ 4.0 ng/ml (median 9.1, range 4.0-25.0). Subsequently, 58 subjects (24.5%) out of the 237 PSA-suspicious men underwent prostate biopsy, and 38 were confirmed as PCa. Until now, the overall PCa incidence in the first screening round is 1.76%. We evaluated the associations between demographic, environmental exposure factors and PCa risk. Age (OR: 2.63; 95% CI: 1.84-3.75, P <0.001), sleep hours (OR: 1.88; 95% CI: 1.37-2.58, P <0.001) and chronic prostatitis history (OR: 2.02; 95% CI: 1.55-2.63, P <0.001) were significantly associated with PSA level. After adjustment for these factors, older age (OR: 4.04; 95% CI: 1.71-9.59, P = 0.002) and no statins use (OR: 3.09; 95% CI: 1.25-7.69, P =0.015) were associated with an elevated risk of PCa. CONCLUSIONS: Although largely underestimated, the incidence of PCa in the targeted Chinese population is higher than expected. Older men have a high risk of harboring PCa. Our study suggests a decreased risk of PCa in men with statins use. Source of Funding: None Shanghai, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e264-e264 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Yongqiang Huang* More articles by this author Chengyuan Gu More articles by this author Xiaojian Qin More articles by this author Yuanyuan Qu More articles by this author Jianfeng Yang More articles by this author Jing Hong More articles by this author li Liu More articles by this author Kefa Zheng More articles by this author Lihua Xu More articles by this author Huaiping Zhao More articles by this author Xiongxion Qian More articles by this author Dingwei Ye More articles by this author Expand All Advertisement PDF downloadLoading ...